Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation.
19 women with anovulation after discontinuing oral contraceptive agents and with normal plasma-prolactin concentrations were treated with bromocriptine. Ovulation and menstruation were restored in 9 of the 13 amenorrhoeic and 5 of the 6 oligomenorrhoeic patients. The success-rate (74%) indicates that bromocriptine is an effective treatment for post-pill anovulation in normoprolactinaemic women.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology; D000858:Anovulation / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001971:Bromocriptine / Q000627:therapeutic use*; D003276:Contraceptives, Oral; D004341:Drug Evaluation; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy*; D009839:Oligomenorrhea / Q000188:drug therapy* / Q000209:etiology; D011388:Prolactin / Q000097:blood*
D003276:Contraceptives, Oral; D004873:Ergolines; D001971:Bromocriptine; D011388:Prolactin